The aim of the project is the development of novel MRI imaging agents for the early diagnosis of platelet-rich thrombi. These novel agents were designed to allow use of multiple reporting techniques such as MRI, UV-fluorescence, near IR fluorescence and to target the platelet specific integrin GPIIbIIIIa. Progress in the understanding of the central importance of platelets in cardiovascular disease, combined with the development of new classes of antiplatelet agents, has dramatically altered the landscape in terms of the clinical management of vascular diseases. There are, however, significant drawbacks with existing therapies, including issues related to limited efficacy and safety. Tirofiban and Abciximab for example are known GPIIb/IIIIa...
Several platelet aIIbb3 integrin antagonists have been designed as preventive agents against the for...
The development of small molecule inhibitors targeting GPVI has promising therapeutic role, as they ...
Thrombocytopenia is a major hematological concern in oxidative stress-associated pathologies and chr...
The aim of the project is the development of novel MRI imaging agents for the early diagnosis of pla...
OBJECTIVES: We aimed to investigate whether early thrombus formation can be visualized with in vivo ...
Objectives: We aimed to investigate whether early thrombus formation can be visualized with in vivo ...
The binding of VWF to GpIb-α is a critical step for maintaining normal haemostasis. The interaction ...
Platelet activation plays a major role in cardio and cerebrovascular diseases, and cancer progressio...
Background: The use of inhibitors of glycoprotein IIb/IIIa (GPIIb/IIIa) has provided dramatic result...
The development of radiolabeled small peptide or peptidomimetic ligands can bind platelets and their...
ObjectivesWe aimed to investigate whether early thrombus formation can be visualized with in vivo ma...
In normal haemostasis, key receptors on human blood platelets, glycoprotein (GP)Ibα of the GPIb-IX-V...
Integrin αIIbβ3 is the central protein in haemostasis and thrombosis; its activation is the first st...
The human glycoprotein (GP)IIb/IIIa belongs to a large family of cation-dependent adhesion molecules...
In this review the roles of platelets and the Gp IIb/IIIa receptor in arterial thromboembolism are d...
Several platelet aIIbb3 integrin antagonists have been designed as preventive agents against the for...
The development of small molecule inhibitors targeting GPVI has promising therapeutic role, as they ...
Thrombocytopenia is a major hematological concern in oxidative stress-associated pathologies and chr...
The aim of the project is the development of novel MRI imaging agents for the early diagnosis of pla...
OBJECTIVES: We aimed to investigate whether early thrombus formation can be visualized with in vivo ...
Objectives: We aimed to investigate whether early thrombus formation can be visualized with in vivo ...
The binding of VWF to GpIb-α is a critical step for maintaining normal haemostasis. The interaction ...
Platelet activation plays a major role in cardio and cerebrovascular diseases, and cancer progressio...
Background: The use of inhibitors of glycoprotein IIb/IIIa (GPIIb/IIIa) has provided dramatic result...
The development of radiolabeled small peptide or peptidomimetic ligands can bind platelets and their...
ObjectivesWe aimed to investigate whether early thrombus formation can be visualized with in vivo ma...
In normal haemostasis, key receptors on human blood platelets, glycoprotein (GP)Ibα of the GPIb-IX-V...
Integrin αIIbβ3 is the central protein in haemostasis and thrombosis; its activation is the first st...
The human glycoprotein (GP)IIb/IIIa belongs to a large family of cation-dependent adhesion molecules...
In this review the roles of platelets and the Gp IIb/IIIa receptor in arterial thromboembolism are d...
Several platelet aIIbb3 integrin antagonists have been designed as preventive agents against the for...
The development of small molecule inhibitors targeting GPVI has promising therapeutic role, as they ...
Thrombocytopenia is a major hematological concern in oxidative stress-associated pathologies and chr...